news

television, radio, and podcasts

Jul 2026: Exploring Access Barriers to Lenacapavir Created by Gilead’s Voluntary License

Feb 2025: Weight loss drugs may become harder to get. What does that mean for patients?. WBUR [NPR station].

Sept 2024: Recap of Novo Nordisk Hearing. BBC World Service.

Sept 2024: What the Maker of Ozempic Doesn’t Want You to Know: It’s Bankrupting America. More Perfect Union.

June 2024: Sanders calls on Ozempic maker to lower price of drug. CNN interview with Senator Bernie Sanders.

Apr 2024: How one state is trying to make weight loss drugs cheaper. NBC.

Apr 2024: American people are ‘sick and tired’ of being ‘ripped off by drug companies’. MSNBC interview with Senator Bernie Sanders.

Mar 2024: New study details costs of making diabetes drugs. CNBC “Fast Money”.

Sept 2023: Hearing: Legislative Proposals to Prevent and Respond to Generic Drug Shortages. C-SPAN.

Sept 2022: California plans to make its own insulin and sell it super-cheap. Really. An Arm and a Leg.

Jan 2022: Report: La vigile attesa. RAI (Radiotelevisione italiana).

Oct 2021: KNX In Depth (live LA current affairs radio show). KNX Radio

print and online media

Jun 22. Call for governments to push for broader access to game-changing HIV prevention drug. Pretoria News.

Apr 30. Gilead won’t sell MSF its HIV drug. Its shareholders should ask why.. MSF.

Apr 16. Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most Apr 9. This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people.. LA Times.

Feb 11. TrumpRx is here and it helps, though a bit less than advertised. Fortune.

Oct 9. Chinese biotechs work on cheaper alternatives to $2M Zolgensma. Endpoints.

Apr 17: Patients of rare disease welcome prospect of dramatic slash in price of drug. The Times of India.

Apr 16: Pharma companies expected to absorb any tariff hit in short term. Reuters.

Mar 26: Indian company can now make Spinal Muscular Atrophy drug, High Court cites public interest. Indian Express.

Mar 24: Delhi HC rejects Roche’s plea to block Natco Pharma on Risdiplam patent. Economic Times.

Mar 18: Balancing Health Rights and Resource Constraints: The Dilemma of Rare Disease Treatment in India. Geneva Health Files.

Mar 13: Trump’s Tariffs Threaten US Drug Prices. Observer Voice.

Mar 12: US tariffs on India will be a bitter pill to swallow. BBC.

Feb 28: High cost patented drugs a crippling blow to those with rare diseases. The Times of India.

Feb 12: For Many, Weight-Loss Drugs Are Pricey. Expanding Access Is Hard. Undark Magazine.

Feb 2: Yale experts weigh in on U.S. WHO exit. Yale News.

Jan 25: People with spinal muscular atrophy demand urgent action from the Centre to reduce medicine costs. The Hindu.

Jan 24: Centre abdicates its constitutional obligation, criticises patients and experts on SMA issue. PharmaBiz.

Jan 20: A Rare Invocation for a Rare Disease?: Government Urged to Invoke Section 100, Patents Act for Rare Disease Medicine. SpicyIP

Jan 8: Experts seek affordable access to medicines for treating Spinal Muscular Atrophy. The Hindu.

Nov 10: How many patients must die to pay the debt to drug innovation: Interview with Dr Melissa Barber. Times of India. Print version

Nov 6: Patient health body opposes move to bar generic SMA drug. Hindustan Times.

Nov 6: Swiss firm Roche bid to prevent India’s Natco Pharma from introducing cheap spinal drug. The Telegraph.

Nov 6: Patents and high price barriers: patients with rare diseases face woes to access medicines from MNCs. The Economic Times.

Nov 5: How a Rs 72 lakh drug for a rare genetic disease could cost just Rs 3,000. India Today.

Oct 28: Rs 72 lakh/year rare-disease drug can be made for Rs 3,000/year, High Court told. Times of India.

Oct 28: Could a Rs 72 lakh drug cost just Rs 3,000? A 24-year-old’s courtroom revelation.. Economic Times.

Oct 7: Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries. New York Times.

Sept 24: Why does Ozempic cost so much? Senators grilled Novo Nordisk CEO for answers. USA Today.

Sept 24: Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad. Washington Post.

Sept 23: Analysts say market forces will lower cost of obesity drugs. Roll Call.

July 5: Health—if you can afford it. Yale Alumni Magazine.

July 2: President Biden: Novo Nordisk, Eli Lilly must stop ripping off Americans with high drug prices. USA Today.

June 26: Wegovy And Ozempic Are Overpriced By 400-500% — Here’s A Quick Solution. Forbes.

May 2: What is behind the insulin shortage in the US?. Al Jazeera.

Apr 29: MSF publishes clinical trial cost, challenges pharma to do the same. The Times of India.

Apr 25: Cost of developing new drugs may be far lower than industry claims, trial reveals. The Guardian.

Apr 24: This Is What a Miracle Drug Looks Like, and It Costs Only $5 to Make. The New York Times.

Apr 24: Diabetes Medication Can Be Manufactured at Lower Cost, New Study Says. Yale News.

Apr 16: «Fett-weg»-Spritzen könnten statt 150 nur 20 Franken kosten. Infosperber.

Apr 6: El “estilo de vida europeo” que asfixia la salud pública de África. El Pais.

Apr 2: MSF denuncia los “desorbitados” precios de los nuevos medicamentos para la diabetes. La Razón (Spain).

Apr 1: MSF study reveals global double standard in diabetes care. Development Aid.

Mar 29: Research flags excessive ‘profiteering’ on diabetes drugs by sections of pharmaceutical industry. The Telegraph India.

Mar 29: Weight-loss drugs cost $1,000 a month but less than 25 to make. Why do we pay so much?. USA Today.

Mar 29: Ozempic costs just $5 to make, a study said. The backlash was swift.. Quartz.

Mar 29: GLP-1 generics would be dramatically cheaper than U.S. price of Ozempic, study shows, but still profitable.. Stat News.

Mar 29: Nyt studie: Populær medicin koster alt, alt for meget. BT (Denmark).

Mar 28: Study: ‘gamechanger’ diabetes drugs cost up to 400 times more than needed. The Guardian.

Mar 28: Sanders presses Novo Nordisk over Ozempic, Wegovy prices. The Washington Post.

Mar 28: MSF’s costing study says newer diabetes drugs and insulin pens priced beyond patient reach. The Hindu.

Mar 28: Bernie Sanders wants to make Ozempic cheaper. Business Insider.

Mar 28: Bernie Sanders implores Novo to cut list prices of Ozempic, Wegovy. Endpoints News.

Mar 28: Costly Ozempic jab, which costs up to $1,300, can be made for just 5, study claims. New York Post.

Mar 28: High prices on GLP-1 meds, insulin pens raise barriers to access in lower-income countries: MSF. Fierce Pharma.

Mar 28: Amerikanen betalen er bijna 1.000 euro per maand voor, maar afvalmiddel Ozempic kan “voor nog geen 5 dollar” gemaakt worden. Het Laatste Nieuws (Belgium).

Mar 28: Ozempic makers could be raking in 40,000% profit — study says diabetes drug can be made for $1/month. The Print.

Mar 28: Medicamentos modernos para a diabetes são vendidos 400 vezes mais caros do que o necessário, denuncia estudo. Sapo (Portugal).

Mar 27: ‘Huge markup on prices of new diabetes medicines and insulin pens’. The Times of India.

Mar 27: Sanders calls for Novo Nordisk to slash Ozempic, Wegovy prices. Office of Bernie Sanders.

Mar 27: Novo Nordisk’s $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests. CNBC.

Mar 27: Weight-loss drug ‘could be profitably made for as little as €4.40 a month’. Irish Examiner.

Mar 27: Sanders calls for Novo Nordisk to slash Ozempic, Wegovy prices. The Hill.

Mar 27: Ozempic, Novo’s $1,000 Diabetes Shot, Can Be Made for Under 5 a Month. Bloomberg.

Mar 27: Ozempic, the $1,000 diabetes drug, can be made for less than 5 a month: study. Ottawa Citizen.

Nov 29: Why it’s time to spotlight the harms of supply shortages. Association of Health Care Journalists.

Sept 15: Health subcommittee members at odds over drafted drug shortage legislation. Fierce Healthcare.

Sept 14: No ‘Silver Bullet’ for Generic Drug Shortage, House Members Told. Medpage Today.

Sept 14: Partisan divide on drug shortages unresolved after hearing. Roll Call News.

May 2: Introducing the 2023 ASHEcon Award Winners. American Society of Health Economists.

July 22: Lucro das maiores farmacêuticas cresce 41% na pandemia. Poder360.

July 22: Farmacêuticas podiam cobrar menos, diz pesquisadora de Harvard. Poder360.

July 12: How Many Variants And Deaths Are We Willing To Accept, Before We Protect The Whole World?. Forbes.

June 17: W.T.O. countries agree to a limited relaxing of patent protections on coronavirus vaccines. New York Times.

May 25: Behind Pfizer’s new not-for-profit deal on patented vaccines and drugs. Devex.

Apr 4: African clinical trial denied access to key COVID drug Paxlovid. Nature.

Mar 5: Novo Nordisk slashes Wegovy price for patients lacking insurance benefits. Washington Post.

Feb 28: Paxlovid e Molnupiravir, pillola anti-Covid: il ricatto delle case farmaceutiche ai sistemi sanitari. Corriere della Sera.

Oct 4: Merck’s Covid-19 pill may be a game-changer, but questions are already being raised about cost. STAT.

Oct 19: WHO-led programme aims to buy antiviral COVID-19 pills for $10 -document. Reuters.

Oct 17: Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?. New York Times.

Oct 7: Merck slammed for 4,000% markup of taxpayer-funded COVID-19 drug. Salon.

Oct 6: Buyers clamor for Merck’s COVID-19 antiviral molnupiravir, but pricing is already controversial. Fierce Pharma.

Oct 6: Covid pill makers accused of selling drug to US at 40 times what it costs to make despite govt funding. Independent.

Oct 5: Merck Sells Federally Financed Covid Pill to U.S. for 40 Times What It Costs to Make. The Intercept.

Oct 4: Why Merck’s Molnupiravir banks heavily on India. Fortune India.

Oct 4: Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill. Health Policy Watch.

Sept 29: La insulina podría ser más barata sin que las farmacéuticas pierdan ganancias, según estudio. El Espectador.

Aug 16: States are trying to cap the price of insulin. Pharmaceutical companies are pushing back. NBC.

Nov 15: Elizabeth Warren’s First Term Plan for Reducing Health Care Costs in America and Transitioning to Medicare for All. Medium.

Oct 8: Why would the government make its own drugs?. New Statesman.

June 25: Why Insulin Defies The Normal Rules Of Economics And Keeps Getting More Expensive. WBUR.

Sept 25: Insulin prices could be much lower and drug makers would still make healthy profits. STAT.

May 31: The drug rebellion fighting big pharma to save the NHS millions. New Scientist.

May 16: EU starts investigation of Aspen’s cancer drug pricing. PmLiVE.

Jan 30: Price hikes for some generic cancer drugs in the UK have skyrocketed. STAT.

Jan 29: Cancer drugs price rise ‘costing NHS millions’. BBC.

Jan 28: Drugs firms are accused of putting cancer patients at risk over price hikes. The Guardian.